| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |